A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Study Identifier:
031-201-00521
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Study Contact Information:
N/A
Study Complete
Subscribe to Updates

Results Available

Study Protocol
Available Languages: English
Statistical Analysis Plan
Available Languages: English

Study Details

Medical Condition
  • Mental disorder
  • Schizophrenia
  • Depression
  • Bipolar Disorder
Study Drug
  • Drug: Placebo IEM tablet
  • Drug: Abilify MyCite®
Date
Jun 2023 - Jul 2023
Phase 1/2
Phase 2/3
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information

Protocol Summary

The primary purpose of the study is to evaluate the positive detection accuracy (PDA) and detection latency measures of the D-Tect patch.

Study Locations

Location
Status
Location
Research site
Garden Grove, California, United States, 92845
Status
N/A